^ALBANY, New York, Feb. 05, 2024 (GLOBE NEWSWIRE) — Curia, a leading
contract research, development and manufacturing company, announced today
announced that it won the CDMO Leadership Award 2024 in the category?Service,
Small Pharma Group”. The awards are now in their 13th year
awarded by Outsourced Pharma and Life Science Leader.
“Curia is honored to receive this award,” said Philip Macnabb,
CEO of Curia.?This award underlines our commitment to the
Creating value for our customers in all our R&D and
Production offers, and we are particularly pleased by the partners who
We support being recognized for this commitment.”
The winners of the CDMO Leadership Awards are selected based on a
Market research from Industry Standard Research (“ISR”) selected CDMOs
to recognize those who meet or exceed their customers’ expectations. For
This year’s award ceremony was presented to 98 contract manufacturers as part of the
annual ISR survey for quality benchmarking in contract manufacturing
evaluated by 23 key performance indicators. The participants in the survey only rate
Companies they have worked with on an outsourced basis in the last 18 months
worked on the project. Curia was created based on feedback from the
Respondents were awarded in the “Small Pharma” category.
?Congratulations to our 2024 CDMO Leadership Award winners. By
your customers will vote for you as the best in global outsourcing
development and manufacturing in the biopharmaceutical industry,” said Louis Garguilo,
Chief Editor and Conference Chair of Outsourced Pharma.?The award winners have
Maintain and expand their skills and expertise
meet the needs of a diverse customer base; You have the
additional quality and reliability delivered for new types of processes
and products are so important and they have the closest relationships with them
Customers built. The year 2023 was ushered in with many unanswered questions.
The winners of the CDMO Leadership Award 2024 are those support companies,
who mastered the challenges of the past year most successfully
have.”
About Curia
Curia is a contract development and manufacturing company (CDMO) with over
30 years of experience, an integrated network of 27 global locations and
over 3,500 employees, working together with its customers in the field of
Biopharmaceuticals bring life-changing therapies to market. Our offer
Biologics and small molecules range from discovery to commercialization
and includes integrated regulatory and analytical capabilities. Our
scientific and process engineering experts as well as our state-of-the-art
Facilities offer first-class experience in the production of active ingredients and
medicines. From curiosity to healing, we take every step to
to improve the lives of patients. Visit us at curiaglobal.com.
Contact the company:
Viana Bhagan
Curia
+1 518 512 2111
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/328a3a12-3a66-4a34-bdc8-
e5de362efb85
°